Autism Spectrum Disorder Trial, Recruiting (NCT06925308)

Autism Spectrum Disorder Trial, Recruiting NCT06925308 Sponsor: UMC Utrecht Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT06925308 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults who are either neurotypical (without a neurodevelopmental condition) or have been diagnosed with Autism Spectrum Disorder (ASD) according to a recognised international diagnostic system
People who are able to understand and follow the study instructions
People who are motivated to take part in research

Who may not be able to join:

People who do not have a strong command of the Dutch language
People who use alcohol and/or recreational drugs during the research period
People whose mental health is considered too unstable to safely participate in the research (confirm with trial site)
People who have prior familiarity with treatment through VGZ (a Dutch healthcare organisation) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nynke Boonstra, Professor, UMC Utrecht

Phone: +31 6 20083507

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06925308

Sponsor: UMC Utrecht

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: +31 6 20083507

More information: https://clinicaltrials.gov/study/NCT06925308

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults who are either neurotypical (without a neurodevelopmental condition) or have been diagnosed with Autism Spectrum Disorder (ASD) according to a recognised international diagnostic system
People who are able to understand and follow the study instructions
People who are motivated to take part in research

Who may not be able to join:

People who do not have a strong command of the Dutch language
People who use alcohol and/or recreational drugs during the research period
People whose mental health is considered too unstable to safely participate in the research (confirm with trial site)
People who have prior familiarity with treatment through VGZ (a Dutch healthcare organisation) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

UMC Utrecht

Registry

ClinicalTrials.gov

Start date

3 February 2025

Est. completion

30 September 2025

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Frequency of eye contact in adults with autism, measured with video, audio and push button.; Duration of eye contact in adults with autism, measured with video, audio and push button.; Arousal during eye contact in adults with autism, measured with skin conductance; Arousal during reflection on ones own eye contact in adults with autism, measured with skin conductance; Reflection on ones own eye contact in adults with autism, measured with video and audio

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov